An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumors, according to a new study led by Weill Cornell Medicine researchers.
A powerful new analytical tool offers a closer look at how tumor cells “shape-shift” to become more aggressive and untreatable, as shown in a study from researchers at Weill Cornell Medicine and the New York Genome Center.
Researchers have uncovered DNA markers associated with retroelements, remnants of ancient viral genetic material, in our genes that act as highly accurate epigenetic clocks predicting chronological age.
The annual competition, slated for Nov. 10-13, allows students to work on open-ended real world problems, showcasing the multifaceted nature of applied mathematics.
The collection of essays by Shepley and other authors is intended for students, academics and practitioners in all design fields to inspire societal contribution and celebrate collaboration.
Neuroscientist Gary Gibson, Ph.D. ’73, keeps a framed picture of a cell derived from the skin cells of a person with Alzheimer’s disease on his office wall.
The image is a memento of Gibson’s breakthrough…
CVS Health is expected to move away from the complex formulas used to set the prices of the prescription drugs it sells, shifting to a simpler model that could change how much Americans pay.
A new preclinical model offers a unique platform for studying the Parkinson’s disease process and suggests a relatively easy method for detecting the disease.
